Propranolol for infantile haemangiomas: A review

Archives of Disease in Childhood

Volumn 96, Issue 9, 2011, Pages 890-893

  Starkey, E ^a   Shahidullah, H ^a  

^a DERBYSHIRE CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA 2 ADRENERGIC RECEPTOR; CORTICOSTEROID; PROPRANOLOL; VINCRISTINE;

AGITATION; AIRWAY OBSTRUCTION; AMBLYOPIA; ASTIGMATISM; BEHAVIOR CHANGE; BRADYCARDIA; BRONCHOSPASM; CANCER SURGERY; CAPILLARY HEMANGIOMA; CHILDHOOD DISEASE; CONGESTIVE HEART FAILURE; CORTICOSTEROID THERAPY; DIARRHEA; DRUG ABSORPTION; DRUG ERUPTION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; EXOPHTHALMOS; FALLOT TETRALOGY; FATIGUE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEPATOMEGALY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; HYPOGLYCEMIA; HYPOTENSION; INCIDENCE; MIGRAINE; MYOPIA; NIGHTMARE; PRIORITY JOURNAL; PTOSIS; REVIEW; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SPINAL DYSRAPHISM; STRABISMUS; SWEATING; THYROID DISEASE; THYROTOXICOSIS;

ADRENERGIC BETA-ANTAGONISTS; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; PROPRANOLOL; TREATMENT OUTCOME;

EID: 80051812916     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.208884     Document Type: Review

References (35)

1. Drolet B.A., Swanson EA, Frieden IJ. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 2008;153:712-715
2. Bowers R.E., Graham EA, Tomlinson KM. The natural history of the strawberry nevus. Arch Dermatol 1960;82:667-680
3. Léauté-Labrèze C., Taïeb A. [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences]. Ann Dermatol Venereol 2008;135:860-862
4. Zimmermann A.P., Wiegand S., Werner J.A., et al. Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol 2010;74:338-342
5. Schwartz R.A., Sidor M.I., Musumeci M.L., et al. Infantile haemangiomas: a challenge in paediatric dermatology. J Eur Acad Dermatol Venereol 2010;24:631-638
6. Buckmiller L.M., Munson P.D., Dyamenahalli U., et al. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 2010;120:676-681
7. Léauté-Labrèze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-2651 (Pubitemid 351831393)
8. Sans V., de la Roque E.D., Berge J., et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124:e423-e431
9. Denoyelle F., Leboulanger N., Enjolras O., et al. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009;73:1168-1172
10. Rosbe K.W., Suh K.Y., Meyer A.K., et al. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 2010;136:658-665
11. Marsciani A., Pericoli R., Alaggio R., et al. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer 2010;54:176.
12. Li Y.C., McCahon E., Rowe N.A., et al. Successful treatment of infantile haemangiomas of the orbit with propranolol. Clin Experiment Ophthalmol 2010;38:554-559
13. Manunza F., Syed S., Laguda B., et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010;162:466-468
14. Haider K.M., Plager D.A., Neely D.E., et al. Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J AAPOS 2010;14:251-256
15. Maturo S., Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol 2010;74:323-325
16. Naouri M., Schill T., Maruani A., et al. Successful treatment of ulcerated haemangioma with propranolol. J Eur Acad Dermatol Venereol 2010;24:1109-1112
17. Qin Z.P., Liu X.J., Li K.L., et al. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety]. Zhonghua Yi Xue Za Zhi 2009;89:3130-3134
18. Wax P.M., Erdman A.R., Chyka P.A., et al. beta-blocker ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2005;43:131-146 (Pubitemid 40675645)
19. Paediatric Formulary Committee. BNF for Children [5th edition]. London: BMJ Publishing Group, Pharmaceutical Press, and RCPCH Publications; 2009.
20. Lawley L.P., Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009;26:610-614
21. Iaccarino G., Ciccarelli M., Sorriento D., et al. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005;97:1182-1189
22. Storch C.H., Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010;163:269-274
23. Fredriksson J.M., Lindquist J.M., Bronnikov G.E., et al. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J Biol Chem 2000;275:13802-13811 (Pubitemid 30257453)
24. Zhang D., Ma Q., Shen S., et al. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell. Pancreas 2009;38:94-100.
25. Kuperman S., Stewart MA. Use of propranolol to decrease aggressive outbursts in younger patients. Open study reveals potentially favorable outcome. Psychosomatics 1987;28:315-319 (Pubitemid 17112024)
26. Love J.N., Howell J.M., Klein-Schwartz W., et al. Lack of toxicity from pediatric beta-blocker exposures. Hum Exp Toxicol 2006;25:341-346 (Pubitemid 44064969)
27. Love J.N., Sikka N. Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers. J Emerg Med 2004;26:309-314 (Pubitemid 38340830)
28. Kallen R.J., Mohler JH, Lin HL. Hypoglycemia: a complication of treatment of hypertension with propranolol. Clin Pediatr (Phila) 1980;19:567-568 (Pubitemid 10087468)
29. Belson M.G., Sullivan K, Geller RJ. Beta-adrenergic antagonist exposures in children. Vet Hum Toxicol 2001;43:361-365 (Pubitemid 33078894)
30. Breur J.M., de Graaf M., Breugeum C.C., et al. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report. Pediatr Dermatol. 2011;28:169-171
31. Holland K.E., Frieden I.J., Frommelt P.C., et al. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010;146:775-778
32. Abbott J., Parulekar M., Shahidullah H., et al. Diarrhea associated with propranolol treatment for hemangioma of infancy (HOI). Pediatr Dermatol 2010;27:558.
33. Horvath F., Jr, Marbury T.C., Uhlemann E.R., et al. Severe diarrhea secondary to propranolol. South Med J 1979;72:367-368 (Pubitemid 9167203)
34. Fraley D.S., Bruns F.J., Segel D.P., et al. Propranolol-related bronchospasm in patients without history of asthma. South Med J 1980;73:238-240 (Pubitemid 10154659)
35. Holmes W.J., Mishra A., Gorst C., et al. Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg 2010;125:420-421